Patent Assignment
Reel/Frame 014242/0753
Ucc-1 Financing Statement
Recorded: 2003-07-08
Received: 2003-07-11
Pages: 7
Assignor
XEOTRON CORPORATION
Executed: 2003-07-02
Assignees
VANGUARD VII, L.P.
525 UNIVERSITY AVENUE, SUITE 600, PALO ALTO, CA, 94301, UNITED STATES
VANGUARD VII-A, L.P.
525 UNIVERSITY AVENUE, SUITE 600, PALO ALTO, CA, 94301, UNITED STATES
VANGUARD VII ACCREDITED AFFILIATES FUND, L.P.
525 UNIVERSITY AVENUE, SUITE 600, PALO ALTO, CA, 94301, UNITED STATES
VANGUARD VII QUALIFIED AFFILIATES FUND, L.P.
525 UNIVERSITY AVENUE, SUITE 600, PALO ALTO, CA, 94301, UNITED STATES
GENESIS PARK L.P.
2001 HERMANN DRIVE, HOUSTON, TX, 77004, UNITED STATES
COGENE BIOTECHN VENTURES, L.P.
711 LOUISIANA, SUITE 3300, HOUSTON, TX, 77002, UNITED STATES
Covered Properties
(4)
Fluidic methods and devices for parallel chemical reactions
Application:
10/237,545 →
Fluidic methods and devices for parallel chemical reactions
Application:
10/245,801 →
Fluidic methods and devices for parallel chemical reactions
Application:
09/897,106 →
Biopolymer Marker Indicative of Disease State Having a Molecular Weight of 1097 Daltons
Application:
09/846,352 →